Baseline (n = 488) (mean, SD) | 4 months (n = 452) | 12 months (n = 438) | Complete responders (all time points) | |
---|---|---|---|---|
Age: mean (SD) | 62.4 | |||
Sex: % female | 76% | |||
Disease duration (years) | 10 | |||
MHQ | 100% (52) | 92% | 90% | 87% |
EQ-5D (utility) | 99.21% (0.58,0.27) | 100% | 98.93% | 99.10% |
EQ-5D (VAS) | 100% (66.71,18.75) | 92.42% | 88.93% | 86.27% |
SF-12 (PCS) | 97% (34,9.67) | 87% | 84% | 76% |
SF-12 (MCS) | 97% (49,10.99) | 87% | 84% | 76% |
SF-6D | 99% (0.63,0.14) | 89% | 86% | 81% |